These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 20189993
1. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. J Biol Chem; 2010 Apr 30; 285(18):14042-51. PubMed ID: 20189993 [Abstract] [Full Text] [Related]
2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW. Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639 [Abstract] [Full Text] [Related]
3. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer. Fei F, Zhang D, Yang Z, Wang S, Wang X, Wu Z, Wu Q, Zhang S. J Exp Clin Cancer Res; 2015 Dec 24; 34():158. PubMed ID: 26702618 [Abstract] [Full Text] [Related]
4. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes. Kim KS, Kim J, Oh N, Kim MY, Park KS. Biochem Biophys Res Commun; 2018 Apr 06; 498(3):509-515. PubMed ID: 29510139 [Abstract] [Full Text] [Related]
5. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. Breast Cancer Res Treat; 1999 May 06; 55(2):127-36. PubMed ID: 10481940 [Abstract] [Full Text] [Related]
6. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. J Cell Biol; 2000 Feb 21; 148(4):779-90. PubMed ID: 10684258 [Abstract] [Full Text] [Related]
7. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression. Rezaei M, Friedrich K, Wielockx B, Kuzmanov A, Kettelhake A, Labelle M, Schnittler H, Baretton G, Breier G. Breast Cancer Res; 2012 Dec 06; 14(6):R154. PubMed ID: 23216791 [Abstract] [Full Text] [Related]
8. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Sehrawat A, Singh SV. Cancer Prev Res (Phila); 2011 Jul 06; 4(7):1107-17. PubMed ID: 21464039 [Abstract] [Full Text] [Related]
9. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). Scribner KC, Behbod F, Porter WW. Oncogene; 2013 May 23; 32(21):2631-9. PubMed ID: 22777354 [Abstract] [Full Text] [Related]
10. Evaluation of the value of GATA3 combined with E-cadherin in the diagnosis of breast cancer. Luo M, Huang Y, Huang J, Huang S, Wei L, Zhang Y, Zhang Z. J BUON; 2019 May 23; 24(3):1038-1044. PubMed ID: 31424658 [Abstract] [Full Text] [Related]
11. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD. Cell Signal; 2014 Dec 23; 26(12):2621-32. PubMed ID: 25152370 [Abstract] [Full Text] [Related]
12. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG. Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057 [Abstract] [Full Text] [Related]
13. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT. J Nutr Biochem; 2015 Jun 13; 26(6):675-85. PubMed ID: 25792283 [Abstract] [Full Text] [Related]
14. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells. Sehrawat A, Kim SH, Vogt A, Singh SV. Carcinogenesis; 2013 Apr 13; 34(4):864-73. PubMed ID: 23276794 [Abstract] [Full Text] [Related]
15. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor. Burton LJ, Dougan J, Jones J, Smith BN, Randle D, Henderson V, Odero-Marah VA. Mol Cell Biol; 2017 Mar 01; 37(5):. PubMed ID: 27956696 [Abstract] [Full Text] [Related]
16. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. Yang S, Du J, Wang Z, Yuan W, Qiao Y, Zhang M, Zhang J, Gao S, Yin J, Sun B, Zhu T. BMC Cancer; 2007 Nov 13; 7():211. PubMed ID: 17997862 [Abstract] [Full Text] [Related]
17. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer. Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q, Sheng W, Wang K, Li X. Tumour Biol; 2015 Apr 13; 36(4):3119-26. PubMed ID: 25501705 [Abstract] [Full Text] [Related]
18. Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation. Du X, Todorov P, Isachenko E, Rahimi G, Mallmann P, Meng Y, Isachenko V. BMC Cancer; 2020 Aug 12; 20(1):753. PubMed ID: 32787800 [Abstract] [Full Text] [Related]
19. Functional characterization of E- and P-cadherin in invasive breast cancer cells. Sarrió D, Palacios J, Hergueta-Redondo M, Gómez-López G, Cano A, Moreno-Bueno G. BMC Cancer; 2009 Mar 03; 9():74. PubMed ID: 19257890 [Abstract] [Full Text] [Related]
20. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM. Oncogene; 2009 Aug 20; 28(33):2940-7. PubMed ID: 19581928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]